SAFS (Safescience, Inc.) formerly IGGI. Hot Potential

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical SAFS (Safescience, Inc.) formerly IGGI. Hot Potential

Previous 10 Next 10

To: rocket who wrote (89)	6/29/1999 6:00:00 PM
From: Mr Zone	of 110

Take your profits and come back up when you make a buck

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Mr Zone who wrote (90)	6/29/1999 6:12:00 PM
From: Daniel Levin	of 110

Excuse Me WKENYON but what exactlly if anything do you know about this stock except for the fact that it is up?????

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Daniel Levin who wrote (91)	6/29/1999 11:24:00 PM
From: Mr Zone	of 110

In all due respect Daniel, most likely know quite abit more than the fact that it is "up" or i wouldn't be short. Are you an authority in biomedical sciences and the therapeutic revelence of these trials and would like to pass on your opinion about how much more money SAFS will need to complete the process to approval or did you just feel like spitting off at me . Give me a good reason to go long at this point. "Uh, cause I am long and dis stock is really good and cures the cancer and if it goes down I'll loose my rent money". Convince me to go long!

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Mr Zone who wrote (92)	6/29/1999 11:56:00 PM
From: Biopyro	of 110

Since Daniel seems to be a SAFS expert, can you please explain me if PSA levels are a good predictor of treatment outcome for prostate cancer? What kind of conclusions can we draw from the recently reported Phase I/II study with GC-590? Is the FDA likely to recognize this surrogate marker as an clinical endpoint in later stage efficacy trials?

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Biopyro who wrote (93)	6/30/1999 9:03:00 AM
From: Mr Zone	of 110

I assume you are asking Daniel your questions are would you like me to answer?

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Mr Zone who wrote (94)	6/30/1999 1:33:00 PM
From: Biopyro	of 110

Sorry for the misunderstanding. Yes, I would like Daniel to answer these questions. He seems to be a very smart SAFS investor (at least in his own opinion). I have yet to find any SAFS long who can make a sensible argument why this stock should have a $350 million market cap. I wish I could find more SAFS shares to sell short!

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Biopyro who wrote (95)	6/30/1999 1:36:00 PM
From: Mr Zone	of 110

OK good, cause I had my post typed and ready for you, just didn't submit. Good Luck Will

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Mr Zone who wrote (96)	7/12/1999 1:47:00 PM
From: Daniel Levin	of 110

Is there anyone still following this stock????

Share	RecommendKeepReply Mark as Last Read Read Replies (3)

To: Daniel Levin who wrote (97)	7/16/1999 11:20:00 PM
From: rocket	of 110

Yes, Daniel, still holding and very pleased with how the company is operating.

Share	RecommendKeepReply Mark as Last Read

To: Daniel Levin who wrote (97)	8/27/1999 11:24:00 AM
From: Ben Wa	of 110

Abe S. might be

Share	RecommendKeepReply Mark as Last Read